Rejoni
Develops a hydrogel system to treat uterine health conditions and prevent scarring
$25MSeries A
Role not disclosedAV
Amed Ventures
Activity from announced rounds
Activity in this selectionhbm-healthcare-bb732a39
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $25M 1 disclosed · full round size, not this investor’s share